Ruizhi Wang

Ruizhi Wang

Auto-generated profile, based on publicly available information

Ruizhi Wang

Department of Neurology, Columbia University Irving Medical Center, New York, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
STSasa Teng
Sasa Teng
ARAngie N. Maldonado Rodriguez
Angie N. Maldonado Rodriguez
RWRuizhi Wang
Ruizhi Wang
XCXinyue Chen
Xinyue Chen
YPYueqing Peng
Yueqing Peng
Neuromodulatory systems play an essential role in regulating brain states and functions. The canonical view is that the release of monoamines including norepinephrine (NE) and serotonin (5-HT) is high during wakefulness and attenuated during sleep, particularly during rapid eye movement (REM) sleep, whereas the cholinergic system is active during both wakefulness and REM sleep and quiescent during non–REM (NREM) sleep. Recent studies have revealed a slow and rhythmic release pattern of neuromodulators during NREM sleep that drives infraslow oscillation (ISO) (0.02 to 0.03 Hz) in the brain. A key question is whether/how the release of different neuromodulators during sleep is coordinated. In this study, we combined 2-site fiber photometry with electroencephalogram/electromyography recording to monitor the release of NE, 5-HT, and acetylcholine in the cortex and hippocampus during sleep and wake cycles. We found that the ISO of these neuromodulators is synchronized during NREM sleep. The synchrony between neuromodulatory systems increases in the oscillatory cycles leading to arousal. Furthermore, pharmacological inhibition of either the 5-HT or NE system eliminates the oscillation of other neuromodulators during NREM sleep. Optogenetic activation of 5-HT or NE neurons during NREM sleep induces the release of other neuromodulators in the absence of sleep-to-wake transitions. These results suggest that the rhythmic neuromodulator releases are highly coordinated in the brain. The synchrony among multiple neuromodulatory systems across brain regions provides a powerful neural mechanism to orchestrate sleep architecture and sleep-related neural processes.

13 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
SAShah Alam
Shah Alam
GDGeorgia Dermentzaki
Georgia Dermentzaki
DCDavid Cabrera-Garcia
David Cabrera-Garcia
MLMiao Li
Miao Li
RWRuizhi Wang
Ruizhi Wang
CZChaolin Zhang
Chaolin Zhang
Recent studies have revealed many alternative exons differentially spliced across diverse neuron types in the mammalian brain, but their links to neuronal physiology remain unclear. Here we characterize a deeply conserved microexon E35a in Ank3 encoding ankyrin-G (AnkG), a multifaceted adaptor protein best known as a master organizer of the axon initial segment (AIS) and as a leading genetic risk factor for bipolar disorder. E35a is predominantly skipped in cortical glutamatergic neurons but included in cortical GABAergic neurons and cerebellar neurons, which is dictated by multiple neuronal splicing factors. In E35a-deletion mice we generated, interneurons show increased excitability and somatic Ca2+ activity, without disruption in AIS. Biochemical analyses suggest that E35a inclusion facilitates AnkG interaction with a protein complex involving inositol trisphosphate receptors (InsP3Rs) important for intracellular Ca2+ signaling. Alternative splicing therefore allows AnkG to modulate neuron type-specific excitability in addition to its ubiquitous pan-neuronal role in organizing the AIS.

1 May 2025 in WIREs RNA
Verified
Journal Article
Open access
WMWilly Munyao
Willy Munyao
MRMd Mostafizur Rahman
Md Mostafizur Rahman
SSSamuel A. Sabzanov
Samuel A. Sabzanov
ECElizabeth H. Chu
Elizabeth H. Chu
RWRuizhi Wang
Ruizhi Wang
MRMatteo Ruggiu
Matteo Ruggiu
Voltage‐gated calcium channels (VGCCs) are multi‐subunit ion channel proteins that control and regulate a wide array of physiological processes. Their dysfunction has been implicated in several neurological, cardiac, psychiatric, endocrine, oncogenic, and muscular disorders. The diverse and specialized cellular functions involving VGCC‐mediated calcium signaling stem from two primary mechanisms: differential and cell‐specific expression of pore‐forming (α1) and auxiliary subunit genes, and extensive alternative splicing of their pre‐mRNA. All the 10 α1‐encoding genes undergo alternative splicing to generate a wide array of cell‐specific CaV variants with distinct biophysical, pharmacological, and protein–protein interaction properties. This proteomic diversity and the associated cell‐specific expression signature of CaV splice variants are tightly regulated by trans‐acting splicing factors—RNA‐binding proteins that control the inclusion or skipping of alternatively spliced exons during post‐transcriptional pre‐mRNA processing. The discovery that several channelopathies are caused by aberrant splicing due to genetic mutations in either cis‐acting binding elements on the pre‐mRNA or in core splicing machinery components highlights the crucial role of alternative splicing in VGCC‐related pathologies. These insights have opened new therapeutic avenues, as targeting the alternative splicing of disease‐associated specific exons has recently emerged as a novel, promising treatment for neurodevelopmental disorders and channelopathies associated with splicing dysfunction.

28 October 2026 in Cell Reports
Verified
Journal Article
Open access
XCXinyue Chen
Xinyue Chen
FRFanwei Ruan
Fanwei Ruan
ARAngie Maldonado Rodriguez
Angie Maldonado Rodriguez
RPRichard Pan
Richard Pan
RWRuizhi Wang
Ruizhi Wang
XLX. Shawn Liu
X. Shawn Liu

14 November 2026 in SLEEP
Verified
Journal Article
Closed access
RWRuizhi Wang
Ruizhi Wang
KCKatherine R Croce
Katherine R Croce
FZFenghua Zhen
Fenghua Zhen
ARAngie N Maldonado Rodriguez
Angie N Maldonado Rodriguez
LZLianyan Zhou
Lianyan Zhou
YPYueqing Peng
Yueqing Peng
Although disruption of sleep behavior is prevalent across different neurodegenerative diseases, there is little understood about the molecular mechanisms that tie them together. To explore this relationship, we turned to the autosomal dominant disorder Huntington’s disease (HD), which shares many features common to more prevalent sporadic diseases, such as abnormal protein accumulation, early cognitive changes, and cell type specific degeneration. Moreover, HD patients suffer from sleep disruption, which precedes the appearance of core clinical features of the disease. We have previously found that upregulation of selective autophagy can prevent the aberrant protein accumulation that is typical of HD and other disorders. Thus, given the robust modeling of HD, we performed sleep analysis in the presence or absence of the upregulation of selective autophagy, to test the hypothesis that the proteinopathy significantly contributes to sleep dysfunction. We found that HD mice display rapid eye movement (REM) sleep impairments and protein aggregation in sleep-related regions including the nucleus accumbens and amygdala. Augmenting selective autophagy in the brain slowed aberrant protein accumulation and ameliorated REM sleep deficits in HD mice. Taken together, these data suggest that the disruption of protein homeostasis may play a key role in sleep dysfunction and disease.